ST-segment elevation myocardial infarction (STEMI)

There are limited data evaluating long-term outcomes of IVUS use in patients with acute myocardial infarction (AMI). The aim of this study was to examine the impact of IVUS-guided PCI on long-term clinical outcomes in patients with AMI.

Thanks to the contribution of a team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science released at TCT 2021 - check out the list here!

Find out more about how the authors managed a 79-year-old male presenting with ACS and lateral ischemia with a calcified and tortuous left circumflex that could not be crossed with balloons... and a 61-year-old male with inferior STEMI presenting with an “undilatable” lesion of the right coronary artery...

Reviewers:

Michele Pighi, Pierre Deharo and Flavio Luciano Ribichini

Watch this session to learn more about complications of coronary perforation, thanks to a selection of two challenging cases: a percutaneous ventricular support device absorbing guidewire during STEMI PCI, as well as a guidewire-induced perforation of tortuous small distal coronary artery.

Watch this session to discover various interesting STEMI cases, such as a multivessel PCI in an acute inferior wall STEMI and coronavirus disease 2019 survivor patient, a cardiogenic shock due to RVMI in MVD with PPCI in RCA, a multimodal thrombo-aspiration in PPCI using pharmaco-invasive strategy in...

Watch this session to discover various papers in STEMI, and learn more about the higher rate of heart failure and in-hospital mortality in STEMI patients during COVID-19 era, the management and outcomes of STEMI patients with current technology, the outcomes of a registry regarding cardiogenic shock...

Watch this session on contemporary challenges in STEMI management to review the role for complete revascularisation in STEMI, to discuss challenges faced in managing STEMI in the COVID era, and to understand how to approach coronary calcification in STEMI.

Through this registry-based analysis, the authors sought to assess short and long-term outcomes of revascularisation in a latecomer STEMI population presenting between 12 to 48 hours of symptom onset.

The objective of the IAMI1 trial was to determine whether early influenza vaccination reduces the risk of cardiovascular events in patients admitted with an acute-MI or high-risk stable coronary artery disease in an adequately powered randomized control trial setting.

Hirotoshi Watanabe (Kyoto, Japan) presented the results of the STOPDAPT-2 ACS trial in a Hot Line session of the ESC Congress 2021. Dejan Milasinovic provides his analysis of this study.